# Survodutide Side Effects: What Studies and Users Report

Source: https://pepvault.app/peptides/survodutide/side-effects

Last updated: 2026-10-06

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Survodutide](https://pepvault.app/peptides/survodutide) Side effects

Peptide questions · Survodutide

# Survodutide side effects: what studies and users report

Reviewed October 2026 Evidence: Established [Published by PepVault](https://pepvault.app/guides/how-we-research)

The side effects most commonly reported for survodutide are nausea, vomiting and diarrhea, among 7 the library lists; the library’s evidence on it includes controlled trials in people.

Its safety note opens: survodutide has no label.

## What is commonly reported with survodutide

- Nausea
- Vomiting
- Diarrhea
- Constipation
- Decreased appetite
- Fatigue
- Higher resting heart rate

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other metabolic & GLP-1 compounds the library lists it for

| Effect | Also listed for (of 24) |
| --- | --- |
| Nausea | 21: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 17 more |
| Vomiting | 18: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 14 more |
| Diarrhea | 20: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 16 more |
| Constipation | 13: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 9 more |
| Decreased appetite | 9: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 5 more |
| Fatigue | 7: Semaglutide, Tirzepatide, Retatrutide, Dulaglutide and 3 more |
| Higher resting heart rate | None: listed for Survodutide alone |

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track survodutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Which survodutide side effects the metabolic & GLP-1 group shares

Across the 25 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (22 of 25), diarrhea (21 of 25), vomiting (19 of 25) and constipation (14 of 25). Survodutide shares 6 of its 7 listed effects with at least one other metabolic & GLP-1 compound; higher resting heart rate is listed for survodutide alone.

## More on survodutide

### Survodutide

- [Survodutide: the full reference](https://pepvault.app/peptides/survodutide)
- [Survodutide dose guide](https://pepvault.app/lab/dosage/survodutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/survodutide-10mg)

### Studies

- [Survodutide: up to 13.0% weight loss at 76 weeks in SYNCHRONIZE-1](https://pepvault.app/research/survodutide-synchronize-1-2026)
- [Survodutide: 12.2% weight loss and less liver fat at 48 weeks](https://pepvault.app/research/survodutide-synchronize-masld-2026)
- [Survodutide: up to 14.9% weight loss at 46 weeks in phase 2 trial](https://pepvault.app/research/survodutide-le-roux-2024)
- [All 4 studies](https://pepvault.app/research#survodutide)

### Compared with

- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Mazdutide vs Survodutide](https://pepvault.app/peptides/compare/mazdutide-vs-survodutide)
- [Survodutide vs Efinopegdutide](https://pepvault.app/peptides/compare/survodutide-vs-efinopegdutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Survodutide questions

- [Survodutide: how long it takes to work](https://pepvault.app/peptides/survodutide/how-long-to-work)

### Terms on this page

- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Placebo](https://pepvault.app/glossary/placebo)

## What the survodutide safety notes say

> The library’s safety note
>
> Survodutide has no label. In phase 3, GI side effects were the most common, mostly mild to moderate and clustered in the dose climb: in SYNCHRONIZE-1 they affected 80.9% (3.6 mg) and 89.7% (6.0 mg) vs 47.9% on placebo; at 6.0 mg in SYNCHRONIZE-MASLD, nausea affected 56% and vomiting 43%, and 20% stopped for GI reasons (4% on placebo). Resting heart rate rose about 3.6 beats per minute (0.8 on placebo). Its phase 3 trials leave out people with a personal or family history of medullary thyroid carcinoma or MEN 2, or a history of pancreatitis, as GLP-1 trials do; SYNCHRONIZE-MASLD saw no confirmed pancreatitis or drug-induced liver injury on survodutide. These are trial findings; review them with your clinician.

> The library’s interaction note
>
> No dedicated interaction studies are published beyond the GLP-1 class effect on stomach emptying: in phase I, a single 1.2 mg dose strongly reduced paracetamol absorption (Boehringer Ingelheim protocol). It is a GLP-1 receptor agonist itself, so it is not combined with another GLP-1 drug. Its glucagon arm raises resting heart rate a little, worth raising with your clinician alongside stimulants or a fast heart rhythm. With insulin or a sulfonylurea, discuss glucose monitoring with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

## Where the survodutide reports come from

The library rates the evidence on survodutide as established: clinical trials or FDA-approved use exist.

Of the library’s 7 research notes on survodutide, 6 rest on randomized trials and 1 on community reports.

Our 4 study pages on survodutide: 3 randomized trials and 1 animal study (mice).

So survodutide has controlled trials in people to set its listed effects against.

## What our survodutide study pages report on safety

### Survodutide: up to 13.0% weight loss at 76 weeks in SYNCHRONIZE-1

Randomized trial, human, 2026: Digestive complaints led the list of side effects, and most cases were mild or moderate: 80.9% of the 3.6 mg arm, 89.7% of the 6.0 mg arm and 47.9% of the placebo arm had them. In a large 76-week phase 3 trial, weekly survodutide led to more weight loss than placebo in people with obesity but no diabetes, and digestive side effects were common.

- [Read the study page: Survodutide: up to 13.0% weight loss at 76 weeks in SYNCHRONIZE-1](https://pepvault.app/research/survodutide-synchronize-1-2026)

### Survodutide: 12.2% weight loss and less liver fat at 48 weeks

Randomized trial, human, 2026: The most common side effects were gastrointestinal, often during dose increases, and mostly mild to moderate. This phase 3 trial adds evidence that survodutide lowered liver fat and body weight more than placebo over 48 weeks in adults with obesity and at-risk fatty liver disease, with mostly gastrointestinal side effects.

- [Read the study page: Survodutide: 12.2% weight loss and less liver fat at 48 weeks](https://pepvault.app/research/survodutide-synchronize-masld-2026)

### Survodutide: up to 14.9% weight loss at 46 weeks in phase 2 trial

Randomized trial, human, 2024: Side effects showed up in 281 of 309 (91%) people on survodutide and 58 of 77 (75%) on placebo. In this phase 2 trial, survodutide lowered bodyweight more than placebo at every dose tested, with larger losses at higher doses and gut side effects in most people taking it.

- [Read the study page: Survodutide: up to 14.9% weight loss at 46 weeks in phase 2 trial](https://pepvault.app/research/survodutide-le-roux-2024)

## Questions people ask

### What are the side effects of survodutide?

The side effects most commonly reported for survodutide are nausea, vomiting and diarrhea, among 7 the library lists; the library’s evidence on it includes controlled trials in people.

### Do survodutide’s side effects come from human studies?

The library rates the evidence on survodutide as established, and the library’s evidence on it includes controlled trials in people.

### Which survodutide side effects are its own?

Among the metabolic & GLP-1 compounds, the library lists higher resting heart rate for survodutide alone.

### Does survodutide interact with other medicines?

The library’s interaction note on survodutide begins: No dedicated interaction studies are published beyond the GLP-1 class effect on stomach emptying: in phase I, a single 1.2 mg dose strongly reduced paracetamol absorption (Boehringer Ingelheim protocol).

## More on survodutide

- [Survodutide: the full library page](https://pepvault.app/peptides/survodutide)
- [Survodutide dose guide](https://pepvault.app/lab/dosage/survodutide)
- [Survodutide: how long it takes to work](https://pepvault.app/peptides/survodutide/how-long-to-work)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track survodutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track survodutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on survodutide

### Survodutide

- [Survodutide: the full reference](https://pepvault.app/peptides/survodutide)
- [Survodutide dose guide](https://pepvault.app/lab/dosage/survodutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/survodutide-10mg)

### Studies

- [Survodutide: up to 13.0% weight loss at 76 weeks in SYNCHRONIZE-1](https://pepvault.app/research/survodutide-synchronize-1-2026)
- [Survodutide: 12.2% weight loss and less liver fat at 48 weeks](https://pepvault.app/research/survodutide-synchronize-masld-2026)
- [Survodutide: up to 14.9% weight loss at 46 weeks in phase 2 trial](https://pepvault.app/research/survodutide-le-roux-2024)
- [All 4 studies](https://pepvault.app/research#survodutide)

### Compared with

- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Mazdutide vs Survodutide](https://pepvault.app/peptides/compare/mazdutide-vs-survodutide)
- [Survodutide vs Efinopegdutide](https://pepvault.app/peptides/compare/survodutide-vs-efinopegdutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Survodutide questions

- [Survodutide: how long it takes to work](https://pepvault.app/peptides/survodutide/how-long-to-work)

### Terms on this page

- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Track survodutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-side-effects-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Survodutide

- [Survodutide in the library](https://pepvault.app/peptides/survodutide)
- [Survodutide: how long it takes to work](https://pepvault.app/peptides/survodutide/how-long-to-work)

## Tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Peptide dosage calculator](https://pepvault.app/tools/peptide-dosage-calculator)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The peptide glossary](https://pepvault.app/glossary)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
